People
Ranking and references
Per is ranked as a Leading Individual by Legal 500 in the field of Life science, where he has been described as “incredibly approachable, responsive and very talented”.
Per Hedman
Per is head of Cirio’s Life Science, Healthcare & Food group and is recognized as a leading lawyer in the life science field. Per regularly advises clients in transactional matters as well as complex regulatory issues that arise in respect of life science, healthcare and food.
Per has extensive experience advising clients in connection with Swedish and cross-border M&A and VC investments particularly with regard to life science, healthcare and food.
Per regularly advises Swedish and foreign clients on complex regulatory and market access matters in his areas of expertise, and his command of life science issues cover both medical devices and pharma.
In addition, Per has significant experience in supporting clients in complex contractual matters whether it be of an operational nature (such as capex investment, supply of raw materials, manufacturing, and distribution) or regarding R&D. Per’s work in this regard is primarily focused in the life science, food, and forestry sectors.
Examples of assignments
- Represented 10x Genomics, Inc., a life science technology company providing solutions for analyzing biological systems, in connection with its acquisition of the Stockholm-based company CartaNA AB.
- Advised Elypta, a Swedish diagnostics company, in connection with its USD 21 million financing round led by Bonnier Ventures.
- Acted for Götgatan Produktion in connection with its sale of the legendary Stockholm theater ”Göta Lejon” to Live Nation.
- Represented Ring Holding in connection with its acquisition of the Scandinavian Burger King franchise and restaurants.
- Acted on behalf of Hadean Ventures in connection with its investments in SAGA Diagnostics AB, Gesynta AB and Alex Therapeutics.
- Advised Share issues in listed companies such as Boule Diagnostics AB (publ.) Intervacc AB and Annexin AB (publ.)
CV
| 2019 | Cirio law firm |
| 2009 - 2018 | Lindahl law firm, Partner |
| 2000 - 2008 | RydinCarlsten Advokatbyrå |
Education
| 2002 | International Law Institute, part of Georgetown Law |
| 2000 | LL.M. / Jur. kand, Uppala University |
| 1998 - 1999 | Purdue University, Krannert School of Management |
Membership
| 2005 | Admitted to the Swedish Bar Association |
| American Bar Association, Health Law and SIL | |
| AIJA, International Association of Young Lawyers |
Languages
| Swedish |
| English |
Ranking and references
Per is ranked as a Leading Individual by Legal 500 in the field of Life science, where he has been described as “incredibly approachable, responsive and very talented”.
Examples of assignments
- Represented 10x Genomics, Inc., a life science technology company providing solutions for analyzing biological systems, in connection with its acquisition of the Stockholm-based company CartaNA AB.
- Advised Elypta, a Swedish diagnostics company, in connection with its USD 21 million financing round led by Bonnier Ventures.
- Acted for Götgatan Produktion in connection with its sale of the legendary Stockholm theater ”Göta Lejon” to Live Nation.
- Represented Ring Holding in connection with its acquisition of the Scandinavian Burger King franchise and restaurants.
- Acted on behalf of Hadean Ventures in connection with its investments in SAGA Diagnostics AB, Gesynta AB and Alex Therapeutics.
- Advised Share issues in listed companies such as Boule Diagnostics AB (publ.) Intervacc AB and Annexin AB (publ.)
CV
| 2019 | Cirio law firm |
| 2009 - 2018 | Lindahl law firm, Partner |
| 2000 - 2008 | RydinCarlsten Advokatbyrå |
Education
| 2002 | International Law Institute, part of Georgetown Law |
| 2000 | LL.M. / Jur. kand, Uppala University |
| 1998 - 1999 | Purdue University, Krannert School of Management |
Membership
| 2005 | Admitted to the Swedish Bar Association |
| American Bar Association, Health Law and SIL | |
| AIJA, International Association of Young Lawyers |
Languages
| Swedish |
| English |